Frequently Asked Questions
The global medical animation market was valued at USD 325.9 Million in 2022.
The medical animation market is expected to grow at a CAGR of 21.30% between 2023 and 2030, reaching USD 1259.2 Million in 2030.
3D mechanism category is the leading segment by type, holding over 29% share in terms of value in 2022.
The drug mechanism of action (MoA) segment governs the demand for medical animation in the world, holding a massive share of over 24% in 2022.
The oncology segment is expected to post the highest CAGR during the forecast period.
North America is fueling the growth of the medical animation industry, with over one-third share in 2022.
The top players include INFUSE MEDIA GROUP, LLC. (US), Random42 Scientific Communication. (UK), Ghost Productions, Inc. (US), AXS Studio. (Canada), Visible Body, Scientific Animations Inc. (US), INVIVO (Canada), Animated Biomedical Productions (Australia), XVIVO (Sweden), Trinsic Animation (US), Understand.com, LLC. (US), Medmovie (US), Trinity Animation (US), Blausen Medical (US), and Vee Technologies (US).
The growth of R&D activities, increased use of 3D computer graphics in medical marketing, and increased public awareness of various health conditions all contribute to the growth of the medical animation industry.
The expected barriers to the medical animation market’s expansion in the targeted period include the rising cost of medical animation services and a shortage of licensed medical animators.
In the upcoming years, it is anticipated that there will be an increase in demand for sophisticated methods like flash and real-time animation.